Fig. 15From: 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one (Abstract O13). crOTU 1614, which includes members of family Eubacteriaceae is associated with decreased relapse after allo-HCT.Cumulative incidence of relapse/POD in the discovery (n = 271) and validation (n = 270) sets stratified by presence or absence of crOTU 1614Back to article page